secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001213900-26-039278
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OSR Holdings signs binding term sheet for VXM01 license; up to $815M in milestones
--------------------------------------------------------------------------------

- Vaximm grants BCME exclusive worldwide license to develop and commercialize VXM01; OSRH is primary recipient of milestone payments.
- BCME responsible for up to $815M in milestone payments payable to OSRH; OSRH to provide Vaximm $30M development financing facility.
- Related-party transaction as BCME is OSRH's largest shareholder; independent fairness opinion required before definitive agreement.
- OSRH retains option to issue up to $15M of common stock at $1.00 per share to BCME Fund, exercisable at OSRH's discretion after 6 months.
- Royalties from ultimate licensee pass through to OSRH after BCME recovers a negative milestone delta including up to 15% preferred return.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026039278/0001213900-26-039278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026039278/ea0284791-8k_osr.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-039278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer